News – Page 868 – Endpoints News

Biogen touts new evidence from the gene therapy company it wagered $800M on

6 years ago

IDO-derived cancer vaccine scores in combo trial with Keytruda; Vir teams up with WuXi on coronavirus antibodies

6 years ago

FDA launches searchable Purple Book

6 years ago

Bicycle Therapeutics takes Roche's Genentech on an up to $2B immuno-oncology ride

6 years ago

When drug value assessment meets real-world evidence: ICER enlists Aetion in pricing evaluation

6 years ago

First US Covid-19 trials set to get underway in Nebraska and Washington, backed by NIH

6 years ago

Mallinckrodt, once the nation’s largest oxycodone producer, announces tentative $1.6B settlement

6 years ago

NIH-partnered Moderna ships off its PhI-ready coronavirus vaccine candidate to a sea of uncertainty

6 years ago

Novartis' plans to wrestle Eylea market share take a hit as Beovu is linked to safety concerns

6 years ago

SoftBank's newest, $165M biotech investment looks for infectious traces in the blood

6 years ago

Eli Lilly scores expanded MACE label for Trulicity; Gilead's CAR-T Yescarta gets in China review line

6 years ago

FDA grants ‘breakthrough’ status to antibiotic alternative as ContraFect rushes to join fight against superbug

6 years ago

NGM Bio takes leap forward in crowded NASH field

6 years ago

Harvard joins coronavirus fight with $115M and a high-profile Chinese partner

6 years ago

Novartis gets a boost in blockbuster multiple sclerosis race with Roche

6 years ago

Sanofi outlines big API plans as coronavirus outbreak reportedly threatens shortage of 150 drugs

6 years ago

Drug approvals: FDA publishes dataset of CDER approvals since 1985

6 years ago

Animal health vet Juergen Horn makes new antibody play for pets, raking $15M in Series A haul

6 years ago

As coronavirus outbreak reaches 'tipping point,' GSK lends adjuvant tech to Chinese partner armed with preclinical ...

6 years ago

The fourth CGRP migraine drug is here. Time for Lundbeck to prove it's worth $2B

6 years ago

Esperion's goldilocks cholesterol fighter wins FDA approval — will its 'traditional' pricing approach spur ...

6 years ago

A space odyssey for new antibiotics: MIT's machine learning approach

6 years ago

Genfit delays high-stakes PhIII NASH readout; Bristol-Myers grabs first Opdivo OK in esophageal cancer

6 years ago

Gilead loses two more patent challenges on HIV pill, setting up courtroom fight in Delaware

6 years ago

First page Previous page 865 866 867868869 870 871 Next page Last page